Literature DB >> 23255557

Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.

Jessie-F Fecteau1, Davorka Messmer, Suping Zhang, Bing Cui, Liguang Chen, Thomas J Kipps.   

Abstract

Chronic lymphocytic leukemia (CLL) cells interact in the marrow with mesenchymal stromal cells (MSCs), which can enhance CLL-cells’ resistance to spontaneous or drug-induced apoptosis. Here we examined the effect of oxygen on the growth and function of MSCs from marrow aspirates of CLL patients. Cultures in ambient oxygen provided for poor recovery and growth of MSCs, which developed features of cell senescence. However, MSCs were propagated readily from the same cells when they were cultured at a physiologic oxygen concentration of 5%. Such MSCs promoted short-term CLL-cell survival in either 5% or ambient O2. However, longer-term CLL-cell survival was enhanced when the cocultures were maintained in 5% O2 versus 21% O2 because of increased MSC proliferation and production of soluble prosurvival factors, such as CXCL12. This study establishes the importance of physiologic oxygen concentration in the propagation and function of MSCs derived from marrow aspirates of CLL patients in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255557      PMCID: PMC3567343          DOI: 10.1182/blood-2012-08-447813

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.

Authors:  Elena A Jones; Anne English; Sally E Kinsey; Liz Straszynski; Paul Emery; Frederique Ponchel; Dennis McGonagle
Journal:  Cytometry B Clin Cytom       Date:  2006-11-15       Impact factor: 3.058

2.  Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Authors:  Neil E Kay; Tait D Shanafelt; Ann K Strege; Yean K Lee; Nancy D Bone; Azra Raza
Journal:  Leuk Res       Date:  2007-01-22       Impact factor: 3.156

3.  Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion.

Authors:  Kotaro R Shibata; Tomoki Aoyama; Yasuko Shima; Kenichi Fukiage; Seiji Otsuka; Moritoshi Furu; Yoshiki Kohno; Kinya Ito; Shunsuke Fujibayashi; Masashi Neo; Tomitaka Nakayama; Takashi Nakamura; Junya Toguchida
Journal:  Stem Cells       Date:  2007-06-14       Impact factor: 6.277

Review 4.  Stromal abnormalities in neoplastic bone marrow diseases.

Authors:  U Dührsen; D K Hossfeld
Journal:  Ann Hematol       Date:  1996-08       Impact factor: 3.673

Review 5.  Oxygen in stem cell biology: a critical component of the stem cell niche.

Authors:  Ahmed Mohyeldin; Tomás Garzón-Muvdi; Alfredo Quiñones-Hinojosa
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

6.  Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

Authors:  L Lagneaux; A Delforge; D Bron; C De Bruyn; P Stryckmans
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

Review 7.  The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.

Authors:  Ruud Das; Holger Jahr; Gerjo J V M van Osch; Eric Farrell
Journal:  Tissue Eng Part B Rev       Date:  2010-04       Impact factor: 6.389

8.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

Authors:  Antonina V Kurtova; Kumudha Balakrishnan; Rong Chen; Wei Ding; Susanne Schnabl; Maite P Quiroga; Mariela Sivina; William G Wierda; Zeev Estrov; Michael J Keating; Medhat Shehata; Ulrich Jäger; Varsha Gandhi; Neil E Kay; William Plunkett; Jan A Burger
Journal:  Blood       Date:  2009-09-17       Impact factor: 22.113

9.  Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Authors:  Wei Ding; Grzegorz S Nowakowski; Traci R Knox; Justin C Boysen; Mary L Maas; Susan M Schwager; Wenting Wu; Linda E Wellik; Allan B Dietz; Asish K Ghosh; Charla R Secreto; Kay L Medina; Tait D Shanafelt; Clive S Zent; Timothy G Call; Neil E Kay
Journal:  Br J Haematol       Date:  2009-09-08       Impact factor: 6.998

10.  Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies.

Authors:  A Stolzing; E Jones; D McGonagle; A Scutt
Journal:  Mech Ageing Dev       Date:  2007-12-17       Impact factor: 5.432

View more
  5 in total

1.  The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.

Authors:  Julia Hoellenriegel; Dirk Zboralski; Christian Maasch; Nathalie Y Rosin; William G Wierda; Michael J Keating; Anna Kruschinski; Jan A Burger
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

2.  Role of high expression of IL-9 in prognosis of CLL.

Authors:  Na Chen; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

3.  IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells.

Authors:  Guo-Hu Di; Yang Liu; Ying Lu; Jin Liu; Chutse Wu; Hai-Feng Duan
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

4.  Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.

Authors:  Md Kamrul Hasan; Laura Rassenti; George F Widhopf; Jian Yu; Thomas J Kipps
Journal:  Leukemia       Date:  2018-12-19       Impact factor: 11.528

Review 5.  Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.

Authors:  Tyler A Herek; Christine E Cutucache
Journal:  Front Oncol       Date:  2017-05-02       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.